ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 52 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2019. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $9,852,000 | +41.5% | 229,652 | +54.1% | 3.20% | +59.4% |
| Q2 2020 | $6,965,000 | +874.1% | 149,017 | +183.4% | 2.01% | +574.5% |
| Q1 2020 | $715,000 | -62.2% | 52,586 | -69.8% | 0.30% | -54.1% |
| Q4 2019 | $1,890,000 | +5.8% | 173,914 | 0.0% | 0.65% | -3.4% |
| Q3 2019 | $1,786,000 | +7665.2% | 173,914 | +7146.4% | 0.67% | +7366.7% |
| Q2 2019 | $23,000 | – | 2,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Green Alpha Advisors, LLC | 8,394 | $264,663 | 0.19% |
| Global Wealth Strategies & Associates | 100 | $3,153 | 0.00% |